DE60215812D1 - Orale zusammensetzungen zur behandlung von adipösen, nicht diabetischen säugetieren, einschliesslich menschen - Google Patents

Orale zusammensetzungen zur behandlung von adipösen, nicht diabetischen säugetieren, einschliesslich menschen

Info

Publication number
DE60215812D1
DE60215812D1 DE60215812T DE60215812T DE60215812D1 DE 60215812 D1 DE60215812 D1 DE 60215812D1 DE 60215812 T DE60215812 T DE 60215812T DE 60215812 T DE60215812 T DE 60215812T DE 60215812 D1 DE60215812 D1 DE 60215812D1
Authority
DE
Germany
Prior art keywords
obesity
mammals
diabetic
treatment
including humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60215812T
Other languages
English (en)
Other versions
DE60215812T2 (de
Inventor
De Barbara Ramon Gomis
Carles Marc Claret
Cirera Joan-Josep Guinovart
Alvarez Josefa Fernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Hispania SL
Original Assignee
Quimica Farmaceutica Bayer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quimica Farmaceutica Bayer SA filed Critical Quimica Farmaceutica Bayer SA
Publication of DE60215812D1 publication Critical patent/DE60215812D1/de
Application granted granted Critical
Publication of DE60215812T2 publication Critical patent/DE60215812T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE60215812T 2001-05-16 2002-05-16 Orale zusammensetzungen zur behandlung von adipösen, nicht diabetischen säugetieren, einschliesslich menschen Expired - Fee Related DE60215812T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200101200 2001-05-16
ES200101200A ES2187276B1 (es) 2001-05-16 2001-05-16 Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
PCT/ES2002/000231 WO2002098435A1 (es) 2001-05-16 2002-05-16 Composiciones orales para el tratamiento de mamíferos obesos y no diabéticos, incluyendo humanos

Publications (2)

Publication Number Publication Date
DE60215812D1 true DE60215812D1 (de) 2006-12-14
DE60215812T2 DE60215812T2 (de) 2007-08-30

Family

ID=8497838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60215812T Expired - Fee Related DE60215812T2 (de) 2001-05-16 2002-05-16 Orale zusammensetzungen zur behandlung von adipösen, nicht diabetischen säugetieren, einschliesslich menschen

Country Status (11)

Country Link
US (1) US7122209B2 (de)
EP (1) EP1400246B1 (de)
AT (1) ATE344042T1 (de)
BR (1) BR0210975A (de)
CA (1) CA2447141A1 (de)
CY (1) CY1105975T1 (de)
DE (1) DE60215812T2 (de)
DK (1) DK1400246T3 (de)
ES (2) ES2187276B1 (de)
PT (1) PT1400246E (de)
WO (1) WO2002098435A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1972342A4 (de) * 2005-07-29 2011-01-12 Univ Barcelona Pharmazeutische zusammensetzungen aus einem wolframsalz (vi) zur behandlung von neurodegenerativen störungen, insbesondere alzheimer-krankheit und schizophrenie
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
CN100515428C (zh) * 2007-04-26 2009-07-22 暨南大学 钨酸锂在制药中的应用
ES2478790B1 (es) * 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
CA2955914C (en) 2014-07-21 2022-09-06 Ignacio Canals Almazan Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025928A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 薬剤
DE4018513C1 (de) * 1989-12-20 1991-05-08 Karl Oexmann, Inh. Wolfgang Oexmann, 4650 Gelsenkirchen, De
US5192197A (en) * 1991-11-27 1993-03-09 Rockwell International Corporation Piezoelectric pump
CH689836A5 (fr) * 1994-01-14 1999-12-15 Westonbridge Int Ltd Micropompe.
US5611214A (en) * 1994-07-29 1997-03-18 Battelle Memorial Institute Microcomponent sheet architecture
US5595763A (en) * 1995-07-19 1997-01-21 Quimica Farmaceutica Bayer S.A. Tungsten (VI) compositions for the oral treatment of diabetes mellitus
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
US6148635A (en) * 1998-10-19 2000-11-21 The Board Of Trustees Of The University Of Illinois Active compressor vapor compression cycle integrated heat transfer device

Also Published As

Publication number Publication date
WO2002098435A1 (es) 2002-12-12
CA2447141A1 (en) 2002-12-12
BR0210975A (pt) 2004-10-05
PT1400246E (pt) 2007-02-28
EP1400246A1 (de) 2004-03-24
DE60215812T2 (de) 2007-08-30
CY1105975T1 (el) 2011-04-06
DK1400246T3 (da) 2007-03-05
ES2275873T3 (es) 2007-06-16
US20040131697A1 (en) 2004-07-08
ATE344042T1 (de) 2006-11-15
ES2187276B1 (es) 2004-08-01
EP1400246B1 (de) 2006-11-02
US7122209B2 (en) 2006-10-17
ES2187276A1 (es) 2003-05-16

Similar Documents

Publication Publication Date Title
RU2004110726A (ru) Применение оксинтомодулина, способ и фармацевтическая композиция для профилактики или лечения избыточной массы тела, способ снижения массы тела
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
ATE294510T1 (de) Netzwerk-bildende und pektin-enthaltende zubereitung
DE69908397D1 (de) Betulinsäure derivate zur behandlung von neuroektodermalen tumoren
SE9603669D0 (sv) New combination
WO2000015205A3 (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
DE69921119D1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
CY1105975T1 (el) Στοματικες συνθεσεις για την θepαπεια παχυσαρκων, μη διαβητικων θηλαστικων, πepιλαμβανομενων των ανθρωπων
ATE418980T1 (de) Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission
Van Ketel Contact urticaria from rubber gloves after dermatitis from thiurams.
DE60019086D1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
DE59909607D1 (de) Tan-1057 derivate
FI974444A (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
BR0102211A (pt) Composição farmacêutica para o tratamento da obesidade ou para facilitar ou promover a perda de peso
ATE185071T1 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
ATE108063T1 (de) Heilmittel zur behandlung von toxoplasmose.
HUP0203534A2 (hu) Triazinonvegyületeket tartalmazó gyógyszerkészítmények alkalmazása parazita protozoonfertőzésekből eredő betegségek kezelésére
EP0971722A1 (de) Aphrodisiakum zur anwendung an den geschlechtsorganen
DE68916443T2 (de) Arzneimittel zur behandlung von kryptosporidiose.
DE50211693D1 (de) Verwendung von derivaten von c2-substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
JP2003160457A (ja) 象牙質知覚過敏予防・治療剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee